BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
See today's BioWorld Science
Home
» EASL 2024: Hepatocyte journey across liver disease and beyond
To read the full article
sign up for free
or
sign in
.
Gastrointestinal
EASL 2024: Hepatocyte journey across liver disease and beyond
June 7, 2024
By
Coia Dulsat
The ongoing European Association for the Study of the Liver 2024 congress in Milan opened yesterday with several presentations on cell plasticity and its role in liver function and regeneration in chronic liver disease situations.
BioWorld Science
Conferences
International Liver Congress
Cancer
Gastrointestinal